Alternative to Buspirone for Tachycardia
For a patient experiencing tachycardia on buspirone, switch to an SSRI (such as sertraline) or a benzodiazepine as first-line alternatives for anxiety treatment. 1
Understanding the Problem
Tachycardia is a recognized adverse effect of buspirone, occurring in approximately 1% of patients in controlled trials 1. More concerning, the FDA label warns that tachycardia can be a component of serotonin syndrome when buspirone is used, particularly with other serotonergic agents 1. This makes discontinuation appropriate when tachycardia develops.
Recommended Alternatives
First-Line: SSRIs (Sertraline preferred)
Sertraline is an excellent alternative, particularly for elderly patients with generalized anxiety disorder. In a randomized trial comparing sertraline (50-100 mg/day) to buspirone in elderly GAD patients, both medications showed significant anxiolytic efficacy with no clinically adverse cardiovascular events 2. While buspirone showed faster onset (superior at 2-4 weeks), by 8 weeks there was no significant difference in efficacy (P=0.16) 2.
- Dosing: Start sertraline 50 mg daily, can increase to 100 mg/day
- Onset: Expect 2-4 weeks for full anxiolytic effect
- Cardiovascular profile: SSRIs do carry some cardiac arrest risk (OR 1.21), but this is lower than tricyclic antidepressants 3
Second-Line: Benzodiazepines
Benzodiazepines are highly effective alternatives with minimal cardiovascular effects. The guideline evidence clearly states that benzodiazepines have shown no changes in QT duration in clinical use, despite some in vitro effects on potassium currents 3. This makes them cardiovascularly safer than buspirone for patients with tachycardia.
- Best options: Diazepam, lorazepam, or alprazolam
- Advantage: Immediate anxiolytic effect without the 1-2 week lag time seen with buspirone
- Caution: Monitor for sedation, dependence potential with long-term use
What to Avoid
Do NOT use:
- Tricyclic antidepressants (significantly higher cardiac arrest risk, OR 1.69) 3
- Ziprasidone or buspirone alternatives in the azapirone class (buspirone itself showed 6% incidence of tachycardia in one study) 4
- MAOIs (contraindicated with recent buspirone use due to hypertensive crisis risk) 1
Clinical Approach
- Discontinue buspirone immediately if tachycardia is persistent or symptomatic
- Assess for serotonin syndrome: Check for other features beyond tachycardia (mental status changes, autonomic instability, neuromuscular changes) 1
- Choose replacement based on patient factors:
- If patient needs immediate relief: benzodiazepine
- If patient can tolerate 2-4 week onset: SSRI (sertraline)
- If elderly patient: sertraline has specific evidence in this population 2
Important Caveat
The cardiovascular guideline notes that patients with pre-existing cardiac conditions (ischemic heart disease, heart failure, structural abnormalities) are at higher risk for arrhythmias with any psychotropic medication 3. If your patient has underlying cardiac disease, obtain baseline ECG and consider cardiology consultation before starting any alternative anxiolytic.